>
The AI Bird-Flu Scenario They Just Published
Japan's first robot ambulance works the 9-1-1 lines for humanoids
Cheap smartphone add-on pinpoints hidden cameras to shut down spies
The $600 Tank That Beats a $10,000 Powerwall
Terrifying AI Behavior Even Its Creators Couldn't Explain
WW3 Near-Miss? AI Hallucinated Nuclear Weapons Components Aboard Chinese Vessel Bound For Iran
Stripe Is Building the Toll Road for the Machine Economy
Toyota Dakar hopeful swaps twin-turbo V6 for hydrogen fuel cells
4-min turbo-inflatable cubic camp castle is now available in the USA
Researchers Used Claude To Hack OpenAI Employee Accounts
Chinese Scientists Develop New Oil Refining Method That Cuts Energy Use by 90%
World's smallest CT scanner fits in the palm of your hand
The Tesla Roadster will blow people's minds
Peter Thiel-Funded Company Anduril to Triple the Number of Autonomous Surveillance Towers...

An exciting new study says that exposure to blue light is an effective, non-pharmaceutical treatment for high blood pressure, which simultaneously reduces the risk of developing cardiovascular disease.
During this study, which was published in the European Journal of Preventative Cardiology, participants were exposed to 30 minutes of whole-body blue light at approximately 450 nanometers – a dose comparable to daily sunlight – followed by exposure to a control light on a different day.
Visible blue light, as opposed to ultraviolet (UV) light, is not carcinogenic. To assess the impact, participants' blood pressure, stiffness of arteries, blood vessel dilation, and blood plasma levels of nitric oxide stores were measured—before, during, and up to two hours after irradiation with both lights.
The researchers who conducted the study from the University of Surrey and Heinrich Heine University Duesseldorf discovered that exposure to whole-body blue light significantly reduced the systolic blood pressure of participants by almost 8 mmHg, compared to the control light which had no impact.